Viva Biotech Holdings VBIZF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.19
- Day Range
- $0.19–0.19
- 52-Week Range
- $0.13–0.43
- Bid/Ask
- $0.00 / $416,000.22
- Shares Outstanding
- 2.06B
- Market Cap
- $403.85M
- Volume/Avg
- 5,500 / 3,775
Key Statistics
- Price/Earnings (Normalized)
- 21.65
- Price/Sales
- 1.59
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 1.72%
Company Profile
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 2,213
- Website
- https://www.vivabiotech.com
Valuation
|
Metric
|
VBIZF
|
|---|---|
Price/Earnings (Normalized) | 21.65 |
Price/Book Value | 0.71 |
Price/Sales | 1.59 |
Price/Cash Flow | 10.63 |
Price/Earnings
VBIZF
Financial Strength
|
Metric
|
VBIZF
|
|---|---|
Quick Ratio | 1.08 |
Current Ratio | 1.54 |
Interest Coverage | 8.00 |
Quick Ratio
VBIZF
Profitability
|
Metric
|
VBIZF
|
|---|---|
Return on Assets (Normalized) | 4.01% |
Return on Equity (Normalized) | 7.30% |
Return on Invested Capital (Normalized) | 5.80% |
Return on Assets
VBIZF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|^VF#K# | LOCK|L#>v | $136B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|^?>B^b& | LOCK|gK$>$ | $84B | |||
| Moderna Inc
MRNA
| LOCK|l<#!$#t | LOCK|S#P | $81B | |||
| argenx SE ADR
ARGX
| LOCK|#qYpk<n | LOCK|>b? | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|f<^^%@@ | LOCK|H#N | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|GX<%dz | LOCK|Kzz?b | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|<#S?!mb | LOCK|Ns%!t | $28B | |||
| Incyte Corp
INCY
| LOCK|^Wjr>m | LOCK|P#@ | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|$r^#x$Y | LOCK|Tvj | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|&@Z!j#! | LOCK|#N^ | $14B |
United States